1. Sankar PS, Pasquale LR, Grosskreutz CL. Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol. 2001. 119:1210–1211.
2. Guier CP. Elevated intraocular pressure and myopic shift linked to topiramate use. Optom Vis Sci. 2007. 84:1070–1073.
3. Li J, Tripathi RC, Tripathi BJ. Drug-induced ocular disorders. Drug Saf. 2008. 31:127–141.
4. Beermann B, Groschinsky-Grind M, Rosen A. Absorption, metabolism, and excretion of hydrochlorothiazide. Clin Pharmacol Ther. 1976. 19(5 Pt 1):531–537.
5. Geanon JD, Perkins TW. Bilateral acute angle-closure glaucoma associated with drug sensitivity to hydrochlorothiazide. Arch Ophthalmol. 1995. 113:1231–1232.
6. Boentert M, Aretz H, Ludemann P. Acute myopia and angle-closure glaucoma induced by topiramate. Neurology. 2003. 61:1306.
7. Rhee DJ, Goldberg MJ, Parrish RK. Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol. 2001. 119:1721–1723.
8. Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol. 2004. 137:193–195.
9. Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology. 2004. 111:109–111.
10. Kerimoglu H, Tokgoz M, Ozturk B, et al. Topiramate-induced acute-onset myopia and central corneal thickening: Pentacam Scheimpflug imaging findings. Can J Ophthalmol. 2009. 44:222–223.
11. Krieg PH, Schipper I. Drug-induced ciliary body oedema: a new theory. Eye (Lond). 1996. 10(Pt 1):121–126.
12. Desai CM, Ramchandani SJ, Bhopale SG, Ramchandani SS. Acute myopia and angle closure caused by topiramate, a drug used for prophylaxis of migraine. Indian J Ophthalmol. 2006. 54:195–197.